Updated Jul 16, 2026
BIERMAN JAMES L has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $3.25M.

James L. Bierman is a corporate director associated with MiMedx Group, Inc. and Tenet Healthcare Corp. He has participated in SEC filings related to his roles but is not widely recognized in public domains.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | MDXG | MIMEDX GROUP, INC. | A — Grant or award | 50.9K | $3.64 | $185K |
| 2026-05-27 | THC | TENET HEALTHCARE CORP | M — Option exercise | 1.3K | — | |
| 2025-06-18 | MDXG | MIMEDX GROUP, INC. | A — Grant or award | 28.6K | $6.47 | $185K |
| 2025-05-29 | THC | TENET HEALTHCARE CORP | S — Open-market sale | 4.6K | $170.00 | $784K |
| 2025-05-27 | THC | TENET HEALTHCARE CORP | S — Open-market sale | 1.6K | $165.72 | $257K |
| 2025-05-22 | THC | TENET HEALTHCARE CORP | S — Open-market sale | 5.0K | $160.00 | $800K |
| 2025-05-22 | THC | TENET HEALTHCARE CORP | S — Open-market sale | 8.8K | $159.35 | $1.41M |
| 2025-05-22 | THC | TENET HEALTHCARE CORP | M — Option exercise | 1.6K | — |
James L. Bierman is a corporate director associated with MiMedx Group, Inc. and Tenet Healthcare Corp. He has participated in SEC filings related to his roles but is not widely recognized in public domains.…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($3.25M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live BIERMAN JAMES L profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.